Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Other Non-Current Assets of $560000.0 for Q1 2019, down 26.22% year-over-year from $759000.0 in Q1 2018, and down 14.76% quarter-over-quarter from $657000.0 in Q4 2018.
Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Pacira BioSciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $560000.0 for Q1 2019.
- In Q1 2019, Other Non-Current Assets fell 26.22% year-over-year to $560000.0; the TTM figure through Mar 2019 stood at $560000.0 (down 26.22% YoY), while the FY2018 annual figure was $657000.0, down 20.36% from the prior year.
- Other Non-Current Assets for Q1 2019 stood at $560000.0, down from $657000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.6 million in Q3 2015, with the low at $406000.0 in Q4 2015.
- The 5-year median for Other Non-Current Assets is $657000.0 (2018), against an average of $945470.6.
- The sharpest annual moves came in 2015 and 2016: Other Non-Current Assets slumped 84.31% in 2015, then surged 53.69% in 2016.
- Pacira BioSciences' Other Non-Current Assets stood at $406000.0 in 2015, then surged by 53.69% to $624000.0 in 2016, then soared by 32.21% to $825000.0 in 2017, then retreated by 20.36% to $657000.0 in 2018, then retreated by 14.76% to $560000.0 in 2019.
- Business Quant data shows PCRX's Other Non-Current Assets at $560000.0 in Q1 2019, $657000.0 in Q4 2018, and $747000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 67.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.34 Mn |
| Mar 31, 2019 | 560,000.00 |
| Dec 31, 2018 | 657,000.00 |
| Sep 30, 2018 | 747,000.00 |
| Jun 30, 2018 | 692,000.00 |
| Mar 31, 2018 | 759,000.00 |
| Dec 31, 2017 | 825,000.00 |
| Sep 30, 2017 | 545,000.00 |
| Jun 30, 2017 | 572,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 624,000.00 |
| Sep 30, 2016 | 651,000.00 |
| Jun 30, 2016 | 677,000.00 |
| Mar 31, 2016 | 481,000.00 |
| Dec 31, 2015 | 406,000.00 |
| Sep 30, 2015 | 2.60 Mn |
| Jun 30, 2015 | 2.25 Mn |
| Mar 31, 2015 | 2.43 Mn |
| Dec 31, 2014 | 2.59 Mn |
| Sep 30, 2014 | 2.95 Mn |